Skip to content
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us

Monthly Sales-2026.04

 

Item Net Revenue
2026.04 790,643
2025.04 689,531
MoM Change 101,112
MoM Change (%) 14.66
2026 1-4 3,133,580
2025 1-4 2,837,409
YoY Change 296,171
YoY Change (%) 10.44
Note

 

PrevPREVIOUSThe Company is invited to attend an institutional investor conference hosted by President Securities on May 27, 2026.
NEXTThe Board of Directors approved the convening of the 2026 Annual Shareholders’ Meeting.Next

Investors

Material Information
Board of Directors
Corporate Governance
Organization
Major Internal Policies
Corporate Governance
Committee
Audit Committee
Remuneration Committee
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders' Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investors
Main Menu
  • Excelsior
    • About Excelsior Medical
    • Enterprise Spirit
    • Development Strategy
    • Related Company
    • Overseas Business
    • Company History
  • Product Description
    • Hemodialysis / Plasma Exchange
    • Blood Bag
    • Artificial Stoma
    • Health Appliances
  • ESG
  • Investors
  • Enterprise Recruitment
  • Contact Us
  • 17F., No. 880, Zhongzheng Rd., Zhonghe Dist., New Taipei City, Taiwan
  • +886-2-2225-1888
[raiseup_copyright]